Clinical outcome and B cell depletion in patients with rheumatoid arthritis receiving rituximab monotherapy in comparison with patients receiving concomitant methotrexate

被引：23

作者：

Owczarczyk, K. ^{[1
]}

Hellmann, M. ^{[1
]}

Fliedner, G.

Roehrs, T. ^{[1
]}

Maizus, K. ^{[1
]}

Passon, D. ^{[2
]}

Hallek, M. ^{[1
]}

Rubbert, A. ^{[1
]}

机构：

[1] Univ Hosp Cologne, Div Rheumatol, Dept Med, D-50924 Cologne, Germany

[2] Univ Cologne, Immunol Lab, Inst Pharmacol, Cologne, Germany

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2008年 / 67卷 / 11期

关键词：

D O I：

10.1136/ard.2007.087023

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：1648 / 1650

页数：5

共 6 条

[1]

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks [J].

Cohen, Stanley B. ;

Emery, Paul ;

Greenwald, Maria W. ;

Dougados, Maxime ;

Furie, Richard A. ;

Genovese, Mark C. ;

Keystone, Edward C. ;

Loveless, James E. ;

Burmester, Gerd-Ruediger ;

Cravets, Matthew W. ;

Hessey, Eva W. ;

Shaw, Timothy ;

Totoritis, Mark C. .

ARTHRITIS AND RHEUMATISM, 2006, 54 (09) :2793-2806

[2]

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J].

Edwards, JCW ;

Szczepanski, L ;

Szechinski, J ;

Filipowicz-Sosnowska, A ;

Emery, P ;

Close, DR ;

Stevens, RM ;

Shaw, T .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2572-2581

[3]

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment - Results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial [J].

Emery, P ;

Fleischmann, R ;

Filipowicz-Sosnowska, A ;

Schechtman, J ;

Szczepanski, L ;

Kavanaugh, A ;

Racewicz, AJ ;

Van Vollenhoven, RF ;

Li, NF ;

Agarwal, S ;

Hessey, EW ;

Shaw, TM .

ARTHRITIS AND RHEUMATISM, 2006, 54 (05) :1390-1400

[4]

Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis [J].

Roll, Petra ;

Palanichamy, Arumugam ;

Kneitz, Christian ;

Dorner, Thomas ;

Tony, Hans-Peter .

ARTHRITIS AND RHEUMATISM, 2006, 54 (08) :2377-2386

[5]

Consensus statement on the use of rituximab in patients with rheumatoid arthritis [J].

Smolen, J. S. ;

Keystone, E. C. ;

Emery, P. ;

Breedveld, F. C. ;

Betteridge, N. ;

Burmester, G. R. ;

Dougados, M. ;

Ferraccioli, G. ;

Jaeger, U. ;

Klareskog, L. ;

Kvien, T. K. ;

Martin-Mola, E. ;

Pavelka, K. .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (02) :143-150

[6]

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis - Comparison with the preliminary American College of Rheumatology and the World Health Organization International League Against Rheumatism criteria [J].

vanGestel, AM ;

Prevoo, MLL ;

vantHof, MA ;

vanRijswijk, MH ;

vandePutte, LBA ;

vanRiel, PLCM .

ARTHRITIS AND RHEUMATISM, 1996, 39 (01) :34-40

← 1 →